▲ | JackeJR 3 days ago | ||||||||||||||||||||||
N=1 study should not have made it into headlines. > Although the research marks a milestone in the search for treatments of type 1 diabetes, it’s important to note that the study involved one one participant, who received a low dose of cells for a short period—not enough for the patient to no longer need to control their blood sugar with injected insulin. An editorial by the journal Nature also says that some independent research groups have failed in their efforts to confirm that Sana’s method provides edited cells with the ability to evade the immune system. | |||||||||||||||||||||||
▲ | thecosas 3 days ago | parent [-] | ||||||||||||||||||||||
Despite that, glad to see it in a human subject. I’ve had T1D for more than 30 years and have seen every headline under the sun with a “cure” always sometime in the next 5 years, so my expectations are properly tempered. Still excited by it but a long way from clinics handing this out as a solution (if it’s viable). | |||||||||||||||||||||||
|